Statins may reduce disease recurrence in patients with ulcerated primary melanoma.
Lena A von SchuckmannKiarash KhosrotehraniR GhiasvandM C B HughesJ C van der PolsM MaltB M SmithersAdéle C GreenPublished in: The British journal of dermatology (2020)
Statins commenced before melanoma diagnosis may reduce the risk of melanoma recurrence, especially in men and in those with ulcerated tumours. Clinical trial evaluation of the potential role of statins in improving the prognosis of high-risk melanoma is warranted.